Technical Analysis for NVNO - enVVeno Medical Corporation

Grade Last Price % Change Price Change
F 3.35 -0.59% -0.02
NVNO closed down 0.59 percent on Friday, November 1, 2024, on 54 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Earnings Movers Other 0.00%
20 DMA Support Bullish -0.59%
Stochastic Sell Signal Bearish 1.21%
Overbought Stochastic Strength 1.21%
1,2,3 Retracement Bearish Bearish Swing Setup -2.90%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.90%
NR7 Range Contraction -2.90%
Narrow Range Bar Range Contraction -2.90%
Weak + Overbought Other -2.90%

   Recent Intraday Alerts

Alert Time
20 DMA Support about 18 hours ago
Down 2 % about 18 hours ago
60 Minute Opening Range Breakdown about 21 hours ago
Rose Above Previous Day's High about 21 hours ago
10 DMA Resistance about 21 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

enVVeno Medical Corporation Description

enVVeno Medical is an Irvine, California based medical device company focused on the development of innovative bioprosthetic (tissue-based) solutions to improve the standard of care in the treatment of venous disease. The Company's lead product, the VenoValveĀ®, is a first-in-class implant being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). In healthy patients, valves inside the veins of the leg assist in propelling blood up the leg, and back to the heart and lungs. Affecting approximately 2.4 million people in the United States, CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Implanted into the femoral vein, the VenoValve is designed to act as a one-way valve, to help restore proper blood flow in the leg. The VenoValve is currently being evaluated in the SAVVE pivotal study with data expected in late 2022.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Vascular Disease Ulcer Veins Circulatory System Angiology Cardiovascular System Chronic Venous Insufficiency Insufficiency Venous Insufficiency Venous Ulcer

Is NVNO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.97
52 Week Low 3.012
Average Volume 138,025
200-Day Moving Average 4.93
50-Day Moving Average 4.18
20-Day Moving Average 3.29
10-Day Moving Average 3.38
Average True Range 0.19
RSI (14) 41.52
ADX 30.87
+DI 12.07
-DI 21.14
Chandelier Exit (Long, 3 ATRs) 2.93
Chandelier Exit (Short, 3 ATRs) 3.59
Upper Bollinger Bands 3.54
Lower Bollinger Band 3.05
Percent B (%b) 0.61
BandWidth 15.07
MACD Line -0.18
MACD Signal Line -0.26
MACD Histogram 0.0728
Fundamentals Value
Market Cap 44.61 Million
Num Shares 13.3 Million
EPS -2.14
Price-to-Earnings (P/E) Ratio -1.57
Price-to-Sales 0.00
Price-to-Book 2.30
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.57
Resistance 3 (R3) 3.57 3.50 3.53
Resistance 2 (R2) 3.50 3.44 3.50 3.52
Resistance 1 (R1) 3.43 3.41 3.39 3.42 3.51
Pivot Point 3.36 3.36 3.34 3.35 3.36
Support 1 (S1) 3.28 3.30 3.25 3.28 3.19
Support 2 (S2) 3.21 3.27 3.21 3.18
Support 3 (S3) 3.14 3.21 3.17
Support 4 (S4) 3.13